Skip to main content
Log in

Non-conventional laryngeal malignancies: a multicentre review of management and outcomes

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

Non-conventional laryngeal malignancies (NSCC) often have limited published data to guide management despite individual histopathological subtypes often exhibiting heterogeneous behaviour, characteristics, and treatment responses compared to laryngeal squamous cell carcinoma (SCC). This study aimed to compare oncological outcomes with SCC, specifically disease-free survival (DFS), disease-specific survival (DSS) and overall survival (OS). Secondary objectives were to compare treatment differences and perform a state of the art review.

Methods

This was a multicentre retrospective cohort study at four tertiary head and neck centres. Survival outcomes between NSCC and SCC patients were analysed with Kaplan–Meier curves and compared by log rank testing. Univariate Cox regression analysis was performed to predict survival by histopathological subgroup, T-stage, N-stage and M-stage.

Results

There were no significant differences in 3-year DFS (p = 0.499), DSS (p = 0.329), OS (p = 0.360) or Kaplan Meier survival curves (DSS/OS) between SCC and overall NSCC groups. However, univariate Cox regression analysis identified “rare” histopathologies (mostly small cell carcinoma) to be predictive of less favourable OS (p = 0.035) but this result was not observed for other NSCC histopathological subgroups. N-stage (p = 0.027) and M-stage (p = 0.048) also predicted OS for NSCC malignancies. Significant differences in treatment modalities were identified with treatment of NSCC typically involving surgical resection and SCC often managed non-surgically (e.g., primary radiotherapy).

Conclusions

Although overall NSCC is managed differently compared to SCC, there do not appear to be differences in survival outcomes between these groups. N-stage and M-stage appear to be more predictive of OS than histopathology than many NSCC subtypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Torabi SJ, Cheraghlou S, Kasle DA et al (2019) Nonsquamous cell laryngeal cancers: Incidence, demographics, care patterns, and effect of surgery. Laryngoscope 129:2496–2505. https://doi.org/10.1002/lary.27785

    Article  PubMed  Google Scholar 

  2. Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91–11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845–852. https://doi.org/10.1200/JCO.2012.43.6097

    Article  CAS  PubMed  Google Scholar 

  3. Wolf GT, Hong WK, Fisher SG et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690. https://doi.org/10.1056/NEJM199106133242402

    Article  PubMed  Google Scholar 

  4. Pfister DG, Spencer S, Adelstein D et al (2020) Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18:873–898. https://doi.org/10.6004/JNCCN.2020.0031

    Article  PubMed  Google Scholar 

  5. Institute NC NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms. Accessed 18 Nov 2020

  6. Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098. https://doi.org/10.1056/NEJMoa031317

    Article  CAS  PubMed  Google Scholar 

  7. Jones TM, De M, Foran B et al (2016) Laryngeal cancer: United Kingdom National Multidisciplinary guidelines. J Laryngol Otol 130:S75–S82. https://doi.org/10.1017/s0022215116000487

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lyhne NM, Primdahl H, Kristensen CA et al (2015) The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. Radiother Oncol 117:91–98. https://doi.org/10.1016/j.radonc.2015.07.004

    Article  PubMed  Google Scholar 

  9. Janssens GO, Rademakers SE, Terhaard CH et al (2014) Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer. Clin Cancer Res 20:1345–1354. https://doi.org/10.1158/1078-0432.CCR-13-1730

    Article  CAS  PubMed  Google Scholar 

  10. National Cancer Registry Ireland Survival statistics. https://www.ncri.ie/data/survival-statistics. Accessed 18 Oct 2020

  11. Brandstorp-Boesen J, Falk RS, Boysen M, Brøndbo K (2017) Impact of stage, management and recurrence on survival rates in laryngeal cancer. PLoS ONE. https://doi.org/10.1371/journal.pone.0179371

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chen L, Deng W, Li C et al (2020) Clinical outcome and comparison between squamous and non-squamous cell carcinoma of the larynx. Acta Otolaryngol 140:195–201

    Article  PubMed  Google Scholar 

  13. Tan E, Mody MD, Saba NF (2018) Systemic therapy in non-conventional cancers of the larynx. Oral Oncol 82:61–68. https://doi.org/10.1016/j.oraloncology.2018.05.005

    Article  PubMed  Google Scholar 

  14. Lin HW, Bhattacharyya N (2008) Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Laryngoscope 118:1003–1013

    Article  PubMed  Google Scholar 

  15. Dai L, Fang Q, Li P et al (2019) Oncologic outcomes of patients with sarcomatoid carcinoma of the hypopharynx. Front Oncol 9:950. https://doi.org/10.3389/fonc.2019.00950

    Article  PubMed  PubMed Central  Google Scholar 

  16. Heidarian A, Wenig BM (2021) The most common mistake in laryngeal pathology and how to avoid it. Head Neck Pathol 15:130–137. https://doi.org/10.1007/s12105-020-01273-6

    Article  PubMed  PubMed Central  Google Scholar 

  17. Viswanathan S, Rahman K, Pallavi S et al (2010) Sarcomatoid (Spindle Cell) carcinoma of the head and neck mucosal region: a clinicopathologic review of 103 cases from a tertiary referral cancer centre. Head Neck Pathol 4:265–275. https://doi.org/10.1007/s12105-010-0204-4

    Article  PubMed  PubMed Central  Google Scholar 

  18. de Araújo AB, Serrano TLI, Pedroso MCM et al (2020) Clinicopathologic diagnostic and prognostic factors of spindle cell carcinoma of upper airway. Pathol Oncol Res 26:1097–1104. https://doi.org/10.1007/s12253-019-00654-9

    Article  PubMed  Google Scholar 

  19. Dubal PM, Marchiano E, Kam D et al (2015) Laryngeal spindle cell carcinoma: a population-based analysis of incidence and survival. Laryngoscope 125:2709–2714. https://doi.org/10.1002/lary.25383

    Article  PubMed  Google Scholar 

  20. Thompson LDR (2011) Laryngeal spindle cell squamous cell carcinoma. Ear Nose Throat J 90:214–216. https://doi.org/10.1177/014556131109000505

    Article  PubMed  Google Scholar 

  21. Zhang M, Li KN, Li C et al (2014) Malignant minor salivary gland carcinomas of the larynx. ORL 76:222–226. https://doi.org/10.1159/000368322

    Article  PubMed  Google Scholar 

  22. Ganly I, Patel SG, Coleman M et al (2006) Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg 132:767–770

    Article  PubMed  Google Scholar 

  23. Sood S, McGurk M, Vaz F (2016) Management of salivary gland tumours: united kingdom national multidisciplinary guidelines. J Laryngol Otol 130:S142–S149. https://doi.org/10.1017/s0022215116000566

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hay AJ, Migliacci J, Karassawa Zanoni D et al (2019) Minor salivary gland tumors of the head and neck—Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type. Cancer 125:3354–3366. https://doi.org/10.1002/cncr.32208

    Article  PubMed  Google Scholar 

  25. Nielsen TK, Bjørndal K, Krogdahl A et al (2012) Salivary gland carcinomas of the larynx: a national study in Denmark. Auris Nasus Larynx 39:611–614. https://doi.org/10.1016/j.anl.2012.02.003

    Article  PubMed  Google Scholar 

  26. Chin OY, Dubal PM, Sheikh AB et al (2017) Laryngeal chondrosarcoma: a systematic review of 592 cases. Laryngoscope 127:430–439. https://doi.org/10.1002/lary.26068

    Article  PubMed  Google Scholar 

  27. Zhou HW, Wang J, Liu Y, Zhang HM (2016) Recurrent chondrosarcoma of the larynx. Medicine (United States). https://doi.org/10.1097/MD.0000000000004118

    Article  PubMed Central  Google Scholar 

  28. Jones HM (1973) Cartilaginous tumours of the head and neck. J Laryngol Otol 87:135–151. https://doi.org/10.1017/S0022215100076714

    Article  CAS  PubMed  Google Scholar 

  29. Coca-Pelaz A, Rodrigo JP, Triantafyllou A et al (2014) Chondrosarcomas of the head and neck. Eur Arch Otorhinolaryngol 271:2601–2609

    PubMed  Google Scholar 

  30. Lee SY, Lim YC, Song MH et al (2005) Chondrosarcoma of the head and neck. Yonsei Med J 46:228–232. https://doi.org/10.3349/ymj.2005.46.2.228

    Article  PubMed  PubMed Central  Google Scholar 

  31. Crist WM, Anderson JR, Meza JL et al (2001) Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091–3102. https://doi.org/10.1200/JCO.2001.19.12.3091

    Article  CAS  PubMed  Google Scholar 

  32. Lee RJ, Lee KK, Lin T et al (2017) Rhabdomyosarcoma of the head and neck: impact of demographic and clinicopathologic factors on survival. Oral Surg Oral Med Oral Pathol Oral Radiol 124:271–279. https://doi.org/10.1016/j.oooo.2017.05.507

    Article  PubMed  Google Scholar 

  33. Russell JO, Revenaugh PC, Budd GT et al (2015) Failed organ preservation strategy for adult laryngeal embryonal rhabdomyosarcoma. Am J Otolaryngol Head Neck Med Surg 36:277–279. https://doi.org/10.1016/j.amjoto.2014.10.011

    Article  Google Scholar 

  34. Jain A, Singh SN, Singhal P, Sharma MP (2015) A rare case of subglottic embryonal rhabdomyosarcoma: managed with the aim of organ preservation. J Laryngol Otol 129:106–109. https://doi.org/10.1017/S002221511400293X

    Article  CAS  PubMed  Google Scholar 

  35. Sivanandan R, Kong CS, Kaplan MJ et al (2004) Laryngeal embryonal rhabdomyosarcoma: A case of cervical metastases 13 years after treatment and a 25-year review of existing literature. Arch Otolaryngol Head Neck Surg 130:1217–1222

    Article  PubMed  Google Scholar 

  36. Ruske DR, Glassford N, Costello S, Stewart IA (1998) Laryngeal rhabdomyosarcoma in adults. J Laryngol Otol 112:670–672. https://doi.org/10.1017/s0022215100141416

    Article  CAS  PubMed  Google Scholar 

  37. Da Mosto MC, Rinaldo A, Marchiori C, Ferlito A (1996) Laryngeal pleomorphic rhabdomyosarcoma: a critical review of the literature. Ann Otol Rhinol Laryngol 105:289–294. https://doi.org/10.1177/000348949610500409

    Article  PubMed  Google Scholar 

  38. Simon JH, Paulino AC, Smith RB, Buatti JM (2002) Prognostic factors in head and neck rhabdomyosarcoma. Head Neck 24:468–473. https://doi.org/10.1002/hed.10070

    Article  PubMed  Google Scholar 

  39. Renner G (2007) Small cell carcinoma of the head and neck: a review. Semin Oncol 34:3–14. https://doi.org/10.1053/j.seminoncol.2006.10.024

    Article  CAS  PubMed  Google Scholar 

  40. Ferlito A, Rinaldo A (2008) Primary and secondary small cell neuroendocrine carcinoma of the larynx: a review. Head Neck 30:518–524

    Article  PubMed  Google Scholar 

  41. Ferlito A, Rinaldo A, Bishop JA et al (2016) Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance. Eur Arch Otorhinolaryngol 273:533–536

    Article  PubMed  Google Scholar 

  42. Van Der Laan TP, Plaat BEC, Van Der Laan BFAM, Halmos GB (2015) Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases. Head Neck 37:707–715. https://doi.org/10.1002/hed.23666

    Article  PubMed  Google Scholar 

  43. Bergamini C, Locati L, Bossi P et al (2016) Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? Oral Oncol 54:54–57. https://doi.org/10.1016/j.oraloncology.2016.01.001

    Article  PubMed  Google Scholar 

  44. Gagne JJ, Thompson L, O’Keefe K, Kesselheim AS (2014) Innovative research methods for studying treatments for rare diseases: methodological review. BMJ. https://doi.org/10.1136/BMJ.G6802

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding was received for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rory J. O’Neill.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Neill, R.J., Hintze, J., Sharifah, A. et al. Non-conventional laryngeal malignancies: a multicentre review of management and outcomes. Eur Arch Otorhinolaryngol 280, 3383–3392 (2023). https://doi.org/10.1007/s00405-023-07937-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-023-07937-7

Keywords

Navigation